NARA Discovery
Article Details
← Back to Search Results
Journal Article

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families

Vittoria Cianci; Angelo Pascarella; Lucia Manzo; Sara Gasparini; Oreste Marsico; Anna Mammì; Carmelo Massimiliano Rao; Claudio Franzutti; Umberto Aguglia; Edoardo Ferlazzo
Metabolic Brain Disease · Vol. 38, Issue 6 · pp. 1905-1912 · 2023

Abstract

Background The GLA c.337T > C (p.Phe113Leu) is a known pathogenic variant associated to late-onset Fabry disease phenotype with predominant cardiac manifestations. A founder effect was demonstrated in a large cohort in the Portuguese region of Guimarães. Herein we report an in-depth phenotype description of a cluster of five Southern Italy families. Methods Family pedigrees of five index males with the p.Phe113Leu variant were obtained and all at-risk relatives underwent biochemical and genetical screening test. Carriers of GLA p.Phe113Leu variant underwent subsequent multidisciplinary clinical and instrumental evaluation. Results Thirty-one (16 M, 15 F) individuals with p.Phe113Leu pathogenic variant were identified. Sixteen out of 31 patients (51.6%) had cardiac manifestations. Notably, myocardial fibrosis was found in 7/8 patients, of whom 2 were under 40 years. Stroke occurred in 4 patients. White matter lesions were detected in 12/19 patients and occurred in 2/10 of subjects under 40 years. Seven females complained of acroparesthesias. Renal involvement occurred in 10 patients. Angiokeratomas were evident in 9 subjects. Eyes, ear, gastrointestinal and pulmonary involvement occurred in the minority of subjects. Conclusion This study demonstrates that a cluster of subjects with p.Phe113Leu pathogenic variant is also present in Southern Italy. Disease manifestations are frequent in both sexes and may occur early in life. Cardiac involvement represents the core manifestation, but neurological and renal involvement is also frequent, suggesting that extra-cardiac complications deserve clinical attention.

Bibliographic Information

JournalMetabolic Brain Disease
PublisherSpringer
Publication Date2023-08-01
Publication Year2023
Volume38
Issue6
Pages1905-1912
Document TypeJournal Article
eISSN1573-7365
DOI10.1007/s11011-023-01216-4

Access Information

NARA Access Coverage1986-01-01~Current
Journal Homepagehttps://www.springer.com/journal/11011
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.